The ongoing health crisis surrounding Covid-19 has caused uncertainty when it comes to treating patients. The importance of avoiding social contact to stop the spread of the virus means there may have to be limited accessibility to treatments like psychotherapy, ECT (electroconvulsive therapy) and rTMS (repetitive transcranial magnetic stimulation). For patients who rely on [...]
About adminThis author has not yet filled in any details.
So far admin has created 22 blog entries.
With the ongoing situation concerning the corona virus, we would like to give you an update on how this affects our way of working at Sooma and our availability for you. We also want to extend a suggestion especially for those of you who are currently treating patients with ECT, rTMS or psychotherapy. Sooma [...]
Sooma Medical awarded EUR 1.2M agreement with VSSHP The Hospital District of Southwest Finland (VSSHP) has entered into a procurement agreement with Sooma Oy for the procurement of direct current stimulation devices (tDCS). The contracts value is approximately EUR 1.2 million and covers the years 2020-2021 with the option to extend until 2024. [...]
Soomalle 1.2 MEUR hankintasopimus VSSHP:n kanssa Varsinais-Suomen Sairaanhoitopiiri (VSSHP) on tehnyt Sooma Oy:n kanssa hankintasopimuksen aivojen tasavirtastimulaatiolaitteiden (tDCS) hankinnasta. Hankintasopimuksen arvo on noin 1,2 miljoonaa euroa ja kattaa vuodet 2020-2021 sekä mahdolliset optiokaudet vuoteen 2024 asti. Hankintasopimus tehtiin kilpailutuksen jälkeen. VSSHP on kansainvälisesti neuromodulaatiohoitojen edelläkävijä. VSSHP:ssa sijaitsee valtakunnallinen neuromodulaatiohoitojen osaamiskeskus. "Hankintaan päädyttiin kustannustehokkuusarvion [...]
Sooma Closes an Investment Round of Over 1.2 Million EUR Sooma Oy, a Finnish medical device company developing non-invasive brain stimulation devices for treatment of neurological and psychiatric disorders, works with Finnish and Italian Angels members to secure a new investment of 1.0m Euro in equity along with a 250k Euro grant by [...]
During the last 20 years, the efficacy and safety of transcranial direct current stimulation (tDCS) in various indications have been studied. One of the most studied indications is Major Depressive Disorder (MDD), for which the efficacy and safety of tDCS has been proven through much research: The Royal College of Psychiatrists gave [...]
Official Press Release - Sooma Medical Awarded US Patent for Advanced Stimulation Electrode. Helsinki, Finland, January 11, 2019 (Newswire.com) - Sooma Medical announces receipt of a U.S. patent for it's new stimulation electrode. The electrode technology is essential for safe and effective delivery of all neuromodulation therapies. The electrode technology developed by Sooma R&D team [...]
Hello all! Interested in Sooma tDCS but want to know what professionals have to say about it? That's great! Below follows four testimonials by medical professionals who are currently treating patients with Sooma tDCS! Keep reading to find out what they think about our therapies! . Testimonial #1 The following [...]
During last few years, transcranial direct current stimulation (tDCS) has become a treatment option for major depressive disorder. The Royal College of Psychiatrists gave out a statement about the subject in February 2017 and the latest meta-analysis concluded tDCS to be as effective as rTMS and antidepressant pharmaceuticals in primary care. Now, [...]
Treatment Outcomes for Sooma Depression Therapy During the last few years, transcranial direct current stimulation (tDCS) has become a well-researched and established treatment option for major depressive disorder. We have collected the latest data from patients who have been treated with the Sooma Depression Therapy and studied the outcomes (this is an updated version of [...]